Effect of Tanreqing Injection (痰热清注射液) on treatment of acute exacerbation of chronic obstructive pulmonary disease with Chinese medicine syndrome of retention of phlegm and heat in Fei (肺)
Authors:
- 1 April 2010
- journal article
- research article
- Published by Springer Nature in Chinese Journal of Integrative Medicine
- Vol. 16 (2) , 131-137
Abstract
To explore the effect of Tanreqing Injection (痰热清注射液, TRQI) on the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) with Chinese medicine syndrome of retention of phlegm and heat in Fei (痰热阻肺证, RPHF).Keywords
This publication has 7 references indexed in Scilit:
- Phosphodiesterase 4 inhibitors in chronic obstructive pulmonary disease: a new approach to oral treatmentBritish Journal of Clinical Pharmacology, 2008
- Can hypertonic saline inhalation influence preformed chemokine and mediator release in induced sputum of chronic obstructive pulmonary disease patients? Comparison with isotonic salineClinical & Experimental Allergy, 2007
- Decreased expression of human aquaporin-5 correlated with mucus overproduction in airways of chronic obstructive pulmonary diseaseActa Pharmacologica Sinica, 2007
- The transforming growth factor- 1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD)Human Molecular Genetics, 2004
- Role of Neutrophils in Mucus Hypersecretion in COPD and Implications for TherapyTreatments in Respiratory Medicine, 2004
- Pharmacology of airway inflammation in asthma and COPDPulmonary Pharmacology & Therapeutics, 2003
- Allergen/irritant interaction ‐ its role in sensitization and allergic diseaseAllergy, 1998